Crossref journal-article
Springer Science and Business Media LLC
Nature Chemical Biology (297)
Bibliography

Roberts, B. E., Duennwald, M. L., Wang, H., Chung, C., Lopreiato, N. P., Sweeny, E. A., Knight, M. N., & Shorter, J. (2009). A synergistic small-molecule combination directly eradicates diverse prion strain structures. Nature Chemical Biology, 5(12), 936–946.

Authors 8
  1. Blake E Roberts (first)
  2. Martin L Duennwald (additional)
  3. Huan Wang (additional)
  4. Chan Chung (additional)
  5. Nicholas P Lopreiato (additional)
  6. Elizabeth A Sweeny (additional)
  7. M Noelle Knight (additional)
  8. James Shorter (additional)
References 50 Referenced 93
  1. Nelson, R. & Eisenberg, D. Structural models of amyloid-like fibrils. Adv. Protein Chem. 73, 235–282 (2006). (10.1016/S0065-3233(06)73008-X) / Adv. Protein Chem. by R Nelson (2006)
  2. Skovronsky, D.M., Lee, V.M.-Y. & Trojanowski, J.Q. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1, 151–170 (2006). (10.1146/annurev.pathol.1.110304.100113) / Annu. Rev. Pathol. by DM Skovronsky (2006)
  3. Prusiner, S.B. Prions. Proc. Natl. Acad. Sci. USA 95, 13363–13383 (1998). (10.1073/pnas.95.23.13363) / Proc. Natl. Acad. Sci. USA by SB Prusiner (1998)
  4. Roberts, B.E. & Shorter, J. Escaping amyloid fate. Nat. Struct. Mol. Biol. 15, 544–546 (2008). (10.1038/nsmb0608-544) / Nat. Struct. Mol. Biol. by BE Roberts (2008)
  5. Wells, J.A. & McClendon, C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001–1009 (2007). (10.1038/nature06526) / Nature by JA Wells (2007)
  6. Ehrnhoefer, D.E. et al. Redirecting aggregation pathways: small molecule-mediated conversion of amyloidogenic polypeptides in unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15, 558–566 (2008). (10.1038/nsmb.1437) / Nat. Struct. Mol. Biol. by DE Ehrnhoefer (2008)
  7. Ehrnhoefer, D.E. et al. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum. Mol. Genet. 15, 2743–2751 (2006). (10.1093/hmg/ddl210) / Hum. Mol. Genet. by DE Ehrnhoefer (2006)
  8. Gestwicki, J.E., Crabtree, G.R. & Graef, I.A. Harnessing chaperones to generate small-molecule inhibitors of amyloid beta aggregation. Science 306, 865–869 (2004). (10.1126/science.1101262) / Science by JE Gestwicki (2004)
  9. Hammarstrom, P., Wiseman, R.L., Powers, E.T. & Kelly, J.W. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299, 713–716 (2003). (10.1126/science.1079589) / Science by P Hammarstrom (2003)
  10. Li, J., Zhu, M., Rajamani, S., Uversky, V.N. & Fink, A.L. Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils. Chem. Biol. 11, 1513–1521 (2004). (10.1016/j.chembiol.2004.08.025) / Chem. Biol. by J Li (2004)
  11. Wang, H. et al. Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs. Proc. Natl. Acad. Sci. USA 105, 7159–7164 (2008). (10.1073/pnas.0801934105) / Proc. Natl. Acad. Sci. USA by H Wang (2008)
  12. Legname, G. et al. Synthetic mammalian prions. Science 305, 673–676 (2004). (10.1126/science.1100195) / Science by G Legname (2004)
  13. Petkova, A.T. et al. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307, 262–265 (2005). (10.1126/science.1105850) / Science by AT Petkova (2005)
  14. Safar, J. et al. Eight prion strains have PrPSc molecules with different conformations. Nat. Med. 4, 1157–1165 (1998). (10.1038/2654) / Nat. Med. by J Safar (1998)
  15. Tanaka, M., Chien, P., Naber, N., Cooke, R. & Weissman, J.S. Conformational variations in an infectious protein determine prion strain differences. Nature 428, 323–328 (2004). (10.1038/nature02392) / Nature by M Tanaka (2004)
  16. Tessier, P.M. & Lindquist, S. Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+]. Nat. Struct. Mol. Biol. 16, 598–605 (2009). (10.1038/nsmb.1617) / Nat. Struct. Mol. Biol. by PM Tessier (2009)
  17. Tribouillard, D. et al. Antiprion drugs as chemical tools to uncover mechanisms of prion propagation. Prion 1, 48–52 (2007). (10.4161/pri.1.1.4053) / Prion by D Tribouillard (2007)
  18. Aguzzi, A. Staining, straining and restraining prions. Nat. Neurosci. 11, 1239–1240 (2008). (10.1038/nn1108-1239) / Nat. Neurosci. by A Aguzzi (2008)
  19. Castilla, J. et al. Crossing the species barrier by PrPSc replication in vitro generates unique infectious prions. Cell 134, 757–768 (2008). (10.1016/j.cell.2008.07.030) / Cell by J Castilla (2008)
  20. Kocisko, D.A. et al. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J. Virol. 77, 10288–10294 (2003). (10.1128/JVI.77.19.10288-10294.2003) / J. Virol. by DA Kocisko (2003)
  21. Trevitt, C.R. & Collinge, J. A systematic review of prion therapeutics in experimental models. Brain 129, 2241–2265 (2006). (10.1093/brain/awl150) / Brain by CR Trevitt (2006)
  22. Kocisko, D.A. et al. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie. Neurosci. Lett. 388, 106–111 (2005). (10.1016/j.neulet.2005.06.053) / Neurosci. Lett. by DA Kocisko (2005)
  23. Balch, W.E., Morimoto, R.I., Dillin, A. & Kelly, J.W. Adapting proteostasis for disease intervention. Science 319, 916–919 (2008). (10.1126/science.1141448) / Science by WE Balch (2008)
  24. Mu, T.W. et al. Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134, 769–781 (2008). (10.1016/j.cell.2008.06.037) / Cell by TW Mu (2008)
  25. Shorter, J. & Lindquist, S. Prions as adaptive conduits of memory and inheritance. Nat. Rev. Genet. 6, 435–450 (2005). (10.1038/nrg1616) / Nat. Rev. Genet. by J Shorter (2005)
  26. Krishnan, R. & Lindquist, S.L. Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435, 765–772 (2005). (10.1038/nature03679) / Nature by R Krishnan (2005)
  27. Tessier, P.M. & Lindquist, S. Prion recognition elements govern nucleation, strain specificity and species barriers. Nature 447, 556–561 (2007). (10.1038/nature05848) / Nature by PM Tessier (2007)
  28. Scheibel, T., Bloom, J. & Lindquist, S.L. The elongation of yeast prion fibers involves separable steps of association and conversion. Proc. Natl. Acad. Sci. USA 101, 2287–2292 (2004). (10.1073/pnas.0308754101) / Proc. Natl. Acad. Sci. USA by T Scheibel (2004)
  29. Scheibel, T. & Lindquist, S.L. The role of conformational flexibility in prion propagation and maintenance for Sup35p. Nat. Struct. Biol. 8, 958–962 (2001). (10.1038/nsb1101-958) / Nat. Struct. Biol. by T Scheibel (2001)
  30. Serio, T.R. et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317–1321 (2000). (10.1126/science.289.5483.1317) / Science by TR Serio (2000)
  31. Shorter, J. & Lindquist, S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304, 1793–1797 (2004). (10.1126/science.1098007) / Science by J Shorter (2004)
  32. Mukhopadhyay, S., Krishnan, R., Lemke, E.A., Lindquist, S. & Deniz, A.A. A natively unfolded yeast prion monomer adopts an ensemble of collapsed and rapidly fluctuating structures. Proc. Natl. Acad. Sci. USA 104, 2649–2654 (2007). (10.1073/pnas.0611503104) / Proc. Natl. Acad. Sci. USA by S Mukhopadhyay (2007)
  33. Shorter, J. & Lindquist, S. Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol. Cell 23, 425–438 (2006). (10.1016/j.molcel.2006.05.042) / Mol. Cell by J Shorter (2006)
  34. Scheibel, T., Kowal, A.S., Bloom, J.D. & Lindquist, S.L. Bidirectional amyloid fiber growth for a yeast prion determinant. Curr. Biol. 11, 366–369 (2001). (10.1016/S0960-9822(01)00099-9) / Curr. Biol. by T Scheibel (2001)
  35. Toyama, B.H., Kelly, M.J., Gross, J.D. & Weissman, J.S. The structural basis of yeast prion strain variants. Nature 449, 233–237 (2007). (10.1038/nature06108) / Nature by BH Toyama (2007)
  36. Derkatch, I.L., Chernoff, Y.O., Kushnirov, V.V., Inge-Vechtomov, S.G. & Liebman, S.W. Genesis and variability of [PSI+] prion factors in Saccharomyces cerevisiae. Genetics 144, 1375–1386 (1996). (10.1093/genetics/144.4.1375) / Genetics by IL Derkatch (1996)
  37. Tanaka, M., Collins, S.R., Toyama, B.H. & Weissman, J.S. The physical basis of how prion conformations determine strain phenotypes. Nature 442, 585–589 (2006). (10.1038/nature04922) / Nature by M Tanaka (2006)
  38. Sawaya, M.R. et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447, 453–457 (2007). (10.1038/nature05695) / Nature by MR Sawaya (2007)
  39. Shewmaker, F., Wickner, R.B. & Tycko, R. Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure. Proc. Natl. Acad. Sci. USA 103, 19754–19759 (2006). (10.1073/pnas.0609638103) / Proc. Natl. Acad. Sci. USA by F Shewmaker (2006)
  40. Diaz-Avalos, R., King, C.Y., Wall, J., Simon, M. & Caspar, D.L. Strain-specific morphologies of yeast prion amyloid fibrils. Proc. Natl. Acad. Sci. USA 102, 10165–10170 (2005). (10.1073/pnas.0504599102) / Proc. Natl. Acad. Sci. USA by R Diaz-Avalos (2005)
  41. Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486–489 (2003). (10.1126/science.1079469) / Science by R Kayed (2003)
  42. O'Nuallain, B. & Wetzel, R. Conformational Abs recognizing a generic amyloid fibril epitope. Proc. Natl. Acad. Sci. USA 99, 1485–1490 (2002). (10.1073/pnas.022662599) / Proc. Natl. Acad. Sci. USA by B O'Nuallain (2002)
  43. Patino, M.M., Liu, J.J., Glover, J.R. & Lindquist, S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273, 622–626 (1996). (10.1126/science.273.5275.622) / Science by MM Patino (1996)
  44. Kryndushkin, D.S., Alexandrov, I.M., Ter-Avanesyan, M.D. & Kushnirov, V.V. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J. Biol. Chem. 278, 49636–49643 (2003). (10.1074/jbc.M307996200) / J. Biol. Chem. by DS Kryndushkin (2003)
  45. Kochneva-Pervukhova, N.V. et al. [PSI+] prion generation in yeast: characterization of the 'strain' difference. Yeast 18, 489–497 (2001). (10.1002/yea.700) / Yeast by NV Kochneva-Pervukhova (2001)
  46. Staszewski, S. et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. N. Engl. J. Med. 341, 1865–1873 (1999). (10.1056/NEJM199912163412501) / N. Engl. J. Med. by S Staszewski (1999)
  47. Burgess, M.R., Skaggs, B.J., Shah, N.P., Lee, F.Y. & Sawyers, C.L. Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance. Proc. Natl. Acad. Sci. USA 102, 3395–3400 (2005). (10.1073/pnas.0409770102) / Proc. Natl. Acad. Sci. USA by MR Burgess (2005)
  48. Spilman, P. et al. A gamma-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains. Proc. Natl. Acad. Sci. USA 105, 10595–10600 (2008). (10.1073/pnas.0803671105) / Proc. Natl. Acad. Sci. USA by P Spilman (2008)
  49. Hennessy, E.J. & Buchwald, S.L. Synthesis of 4,5-dianilinophthalimide and related analogues for potential treatment of Alzheimer's disease via palladium-catalyzed amination. J. Org. Chem. 70, 7371–7375 (2005). (10.1021/jo051096o) / J. Org. Chem. by EJ Hennessy (2005)
  50. Trinks, U. et al. Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase. J. Med. Chem. 37, 1015–1027 (1994). (10.1021/jm00033a019) / J. Med. Chem. by U Trinks (1994)
Dates
Type When
Created 15 years, 9 months ago (Nov. 13, 2009, 2:03 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 3:45 p.m.)
Indexed 2 months, 3 weeks ago (June 9, 2025, 12:29 p.m.)
Issued 15 years, 10 months ago (Nov. 1, 2009)
Published 15 years, 10 months ago (Nov. 1, 2009)
Published Online 15 years, 10 months ago (Nov. 1, 2009)
Published Print 15 years, 9 months ago (Dec. 1, 2009)
Funders 0

None

@article{Roberts_2009, title={A synergistic small-molecule combination directly eradicates diverse prion strain structures}, volume={5}, ISSN={1552-4469}, url={http://dx.doi.org/10.1038/nchembio.246}, DOI={10.1038/nchembio.246}, number={12}, journal={Nature Chemical Biology}, publisher={Springer Science and Business Media LLC}, author={Roberts, Blake E and Duennwald, Martin L and Wang, Huan and Chung, Chan and Lopreiato, Nicholas P and Sweeny, Elizabeth A and Knight, M Noelle and Shorter, James}, year={2009}, month=nov, pages={936–946} }